Jong; Ling

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jong; Ling.The latest application filed is for "map4k4 (hgk) inhibitors".

Company Profile

0.17.13

Jong; Ling - Sunnyvale CA
Jong; Ling - Menlo Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lipoxygenase inhibitors Grant 10,646,471 - Jong	2020-05-12
MAP4K4 (HGK) inhibitors Grant 10,000,451 - Jong , et al. June 19, 2	2018-06-19
MAP4K4 (HGK) Inhibitors App 20170320824 - Jong; Ling ; et al.	2017-11-09
Lipoxygenase Inhibitors App 20170095450 - Jong; Ling	2017-04-06
Lipoxygenase Inhibitors App 20130345214 - Jong; Ling	2013-12-26
Analogs of indole-3-carbinol and their use as agents against infection Grant 8,399,502 - Jong , et al. March 19, 2	2013-03-19
Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection App 20120283240 - Jong; Ling ; et al.	2012-11-08
Analogs of indole-3-carbinol and their use as agents against infection Grant 8,278,341 - Jong , et al. October 2, 2	2012-10-02
Induction of apoptosis in cancer cells Grant RE42,700 - Dawson , et al. September 13, 2	2011-09-13
Analogs of Indole-3-Carbinol and Their Use as Agents Against Infection App 20100069355 - Jong; Ling ; et al.	2010-03-18
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents Grant 7,666,897 - Jong , et al. February 23, 2	2010-02-23
Analogs of Indole-3-Carbinol Metabolites as Chemotherapeutic and Chemopreventive Agents App 20090023796 - JONG; Ling ; et al.	2009-01-22
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents Grant 7,429,610 - Jong , et al. September 30, 2	2008-09-30
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents Grant 7,078,427 - Jong , et al. July 18, 2	2006-07-18
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents App 20060128785 - Jong; Ling ; et al.	2006-06-15
Induction of apoptosis in cancer cells Grant 7,053,071 - Dawson , et al. May 30, 2	2006-05-30
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents Grant 6,800,655 - Jong , et al. October 5, 2	2004-10-05
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents App 20040157906 - Jong, Ling ; et al.	2004-08-12
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Grant 6,747,018 - Tanabe , et al. June 8, 2	2004-06-08
Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents App 20040043965 - Jong, Ling ; et al.	2004-03-04
Induction of apoptosis in cancer cells App 20030176506 - Dawson, Marcia J. ; et al.	2003-09-18
Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use App 20030153543 - Tanabe, Masato ; et al.	2003-08-14
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Grant 6,548,491 - Tanabe , et al. April 15, 2	2003-04-15
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Grant 6,503,896 - Tanabe , et al. January 7, 2	2003-01-07
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use App 20020032181 - Tanabe, Masato ; et al.	2002-03-14
Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use App 20020032180 - Tanabe, Masato ; et al.	2002-03-14
Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use Grant 6,281,205 - Tanabe , et al. August 28, 2	2001-08-28
RXR homodimer formation Grant 5,824,484 - Pfahl , et al. October 20, 1	1998-10-20
Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors Grant 5,466,861 - Dawson , et al. November 14, 1	1995-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.